SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-122193
Filing Date
2011-05-02
Accepted
2011-05-02 17:27:43
Documents
10
Period of Report
2011-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 30324
2 LETTER AGREEMENT dex11.htm EX-1.1 89327
3 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION dex31.htm EX-3.1 77245
4 FORM OF SERIES 12 PREFERRED STOCK CERTIFICATE dex41.htm EX-4.1 10398
5 FORM OF COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 64218
6 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 150862
7 PRESS RELEASE dex991.htm EX-99.1 10462
8 GRAPHIC g180395g27i21.jpg GRAPHIC 2297
9 GRAPHIC g180395g36v54.jpg GRAPHIC 3499
10 GRAPHIC g180395g68n46.jpg GRAPHIC 1335
  Complete submission text file 0001193125-11-122193.txt   444436
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 11802063
SIC: 2834 Pharmaceutical Preparations